Home/Filings/4/0002090209-25-000005
4//SEC Filing

Caudill Cortney 4

Accession 0002090209-25-000005

CIK 0001159036other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 5:18 PM ET

Size

7.9 KB

Accession

0002090209-25-000005

Insider Transaction Report

Form 4
Period: 2025-10-03
Caudill Cortney
SVP, CHIEF OPERATING OFFICER
Transactions
  • Award

    Option to Purchase Common Stock

    2025-10-03+9,0319,031 total
    Exercise: $68.98From: 2026-10-03Exp: 2035-10-03Common Stock (9,031 underlying)
  • Award

    Restricted Stock Units

    2025-10-03+3,6253,625 total
    Exercise: $0.00From: 2026-10-03Common Stock (3,625 underlying)
Footnotes (2)
  • [F1]This option vests one-fourth on such date and then 1/48th monthly thereafter.
  • [F2]This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.

Issuer

HALOZYME THERAPEUTICS, INC.

CIK 0001159036

Entity typeother

Related Parties

1
  • filerCIK 0002090209

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 5:18 PM ET
Size
7.9 KB